Evidence map›Paper›PMID 30841648›Full record

ArticleMolecules (Basel, Switzerland)2019

The Extracts of

Xianxian Wei, Lijie Xia, Dilinigeer Ziyayiding, Qiuyan Chen, Runqing Liu, Xiaoyu Xu, Jinyao Li

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Low-ThujoneMolecules (Basel, Switzerland) · 2026
    Article
  3. Frontiers in oncology · 2025
    Article
  4. Article
  5. Article
  6. Total Flavonoids inInternational journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Antitumoral Properties of Natural Products.Molecules (Basel, Switzerland) · 2020
    Article
  11. Romanian Wormwood (Molecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xianxian WeiXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, Xinjiang 830046, China. 15099141611@189.cn.
Lijie XiaXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, Xinjiang 830046, China. xialijie1219@163.com.
Dilinigeer ZiyayidingXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, Xinjiang 830046, China. dilnigar9696@sina.com.
Qiuyan ChenThese two authors contributed equally.. m15276567620_1@163.com.
Runqing Liu
Xiaoyu Xu
Jinyao Li
Xinjiang University · CN

Funding

1000 Young Talents Program of China 2015Chinese National Natural Science Foundation Grant 31860258Chinese National Natural Science Foundation Grant U1803381"Tianshan Youth Project" Young Ph.D. Science and Technology talents Project 2017Q077
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisArtemisia absinthiumCell Cycle CheckpointsCell Line, TumorEndoplasmic Reticulum StressHumansInhibitory Concentration 50Membrane Potential, MitochondrialMitochondriaPlant ExtractsReactive Oxygen SpeciesSignal TransductionAntineoplastic Agents, PhytogenicPlant ExtractsReactive Oxygen SpeciesapoptosisArtemisia absinthiumendoplasmic reticulum stressmitochondrial-dependent pathway

Identifiers

PMID30841648
PMCPMC6429450
OpenAlexW2919803529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.